A combination of corticosteroids and vincristine achieved complete remission in 9 out of 15 cases of ‘agranular’ blastic crisis supervening in chronic granulocytic leukaemia, but failed to do so in other 9 cases in which the metamorphosis was of more progressive character and with a ‘granular’ cytomorphology. In the first group, although remissions were generally short, the completeness of their character made them fully worthwhile for the patients. The greater sensitivity of the undifferentiated, ‘agranular’ blast cell is not restricted to its reactivity to vincristine, but appears to be a general cytopharmacological feature
This content is only available via PDF.
© 1973 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.